Leila Simani
Impact in
- Neurology top 2%
- Long-Term Effects of COVID-19
- Neuroinflammation and Neurodegeneration Mechanisms
- Sensory Systems top 5%
- Olfactory and Sensory Function Studies
Papers in
-
- Epilepsy research and treatment 12
- Psychosomatic Disorders and Their Treatments 4
- Neurology 16
- Long-Term Effects of COVID-19 8
- Co-authors
- Ali A. Asadi‐Pooya (7 shared papers)Mahtab Ramezani (15 shared papers)Marjan Asadollahi (10 shared papers)Hossein Pakdaman (4 shared papers)Mohammadreza Hajiesmaeili (8 shared papers)Omidvar Rezaei (8 shared papers)Abbas Aliaghaei (3 shared papers)Nader Akbari Dilmaghani (2 shared papers)
- Journals
- ACS Chemical Neuroscience (3 papers)Multiple Sclerosis and Related Disorders (2 papers)Epilepsy & Behavior (2 papers)Epilepsia Open (2 papers)Journal of Molecular Neuroscience (2 papers)
- Partner nations
- IranUnited StatesCanada
In The Last Decade
Leila Simani
42 papers receiving 1.3k citations
Leila Simani's Hit Papers
Peers
Comparison fields: 5 of 119
- Neurology 730
- Sensory Systems 133
- Infectious Diseases 392
- Critical Care and Intensive Care Medicine 103
- Neurology 160
Countries citing papers authored by Leila Simani
This map shows the geographic impact of Leila Simani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Simani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Simani more than expected).
Fields of papers citing papers by Leila Simani
This network shows the impact of papers produced by Leila Simani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Simani. The network helps show where Leila Simani may publish in the future.
Co-authors
The 25 scholars most cited alongside Leila Simani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Central nervous system manifestations of COVID-19: A systematic review Hit paper breakdown → | 2020 | 530 |
| 2 | 2020 | 127 | |
| 3 | 2021 | 105 | |
| 4 | 2021 | 65 | |
| 5 | 2020 | 56 | |
| 6 | 2020 | 50 | |
| 7 | 2018 | 40 | |
| 8 | S100 B: A new concept in neurocritical care. | 2017 | 34 |
| 9 | 2017 | 31 | |
| 10 | 2018 | 25 | |
| 11 | 2021 | 24 | |
| 12 | 2018 | 20 | |
| 13 | 2020 | 19 | |
| 14 | 2019 | 18 | |
| 15 | 2018 | 18 | |
| 16 | 2018 | 16 | |
| 17 | 2020 | 14 | |
| 18 | 2023 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2016 | 8 |
About Leila Simani
Leila Simani is a scholar working on Psychiatry and Mental health, Neurology, Molecular Biology, Infectious Diseases and Epidemiology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epilepsy research and treatment (12 papers), Long-Term Effects of COVID-19 (8 papers), Coenzyme Q10 studies and effects (4 papers), Advanced battery technologies research (4 papers), Acute Ischemic Stroke Management (4 papers), Ion channel regulation and function (4 papers), Psychosomatic Disorders and Their Treatments (4 papers) and S100 Proteins and Annexins (3 papers). The work is most often cited by research in Neurology (730 citations), Sensory Systems (133 citations), Infectious Diseases (392 citations), Critical Care and Intensive Care Medicine (103 citations) and Neurology (160 citations). Leila Simani has collaborated with scholars based in Iran, United States and Canada. Frequent co-authors include Ali A. Asadi‐Pooya, Mahtab Ramezani, Marjan Asadollahi, Hossein Pakdaman, Mohammadreza Hajiesmaeili, Omidvar Rezaei, Abbas Aliaghaei, Nader Akbari Dilmaghani, Fatemeh Ghorbani and Mastooreh Sagharichi. Their work appears in journals such as ACS Chemical Neuroscience, Multiple Sclerosis and Related Disorders, Epilepsy & Behavior, Epilepsia Open and Journal of Molecular Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.